CFMS Conformis Inc

Price (delayed)

$1.2

Market cap

$8.99M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.99

Enterprise value

-$12.64M

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, ...

Highlights
The EPS rose by 21% since the previous quarter
Conformis's net income has increased by 20% from the previous quarter
Conformis's gross profit has shrunk by 65% YoY but it has increased by 5% QoQ
Conformis's gross margin has decreased by 43% YoY but it has increased by 2.2% QoQ
The equity has contracted by 46% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of CFMS
Market
Shares outstanding
7.5M
Market cap
$8.99M
Enterprise value
-$12.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.17
Price to sales (P/S)
0.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.2
Earnings
Revenue
$62.05M
EBIT
-$48.48M
EBITDA
-$42.93M
Free cash flow
-$52.07M
Per share
EPS
-$6.99
Free cash flow per share
-$7.21
Book value per share
$7.21
Revenue per share
$8.59
TBVPS
$13.03
Balance sheet
Total assets
$94.05M
Total liabilities
$39.87M
Debt
$27.5M
Equity
$54.18M
Working capital
$65.2M
Liquidity
Debt to equity
0.51
Current ratio
5.63
Quick ratio
4.19
Net debt/EBITDA
0.5
Margins
EBITDA margin
-69.2%
Gross margin
37.4%
Net margin
-81.3%
Operating margin
-74.6%
Efficiency
Return on assets
-45.4%
Return on equity
-73.5%
Return on invested capital
-86%
Return on capital employed
-60.6%
Return on sales
-78.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CFMS stock price

How has the Conformis stock price performed over time
Intraday
-2.44%
1 week
-9.09%
1 month
-28.99%
1 year
-93.13%
YTD
-63.86%
QTD
-63.86%

Financial performance

How have Conformis's revenue and profit performed over time
Revenue
$62.05M
Gross profit
$23.21M
Operating income
-$46.28M
Net income
-$50.47M
Gross margin
37.4%
Net margin
-81.3%
Conformis's gross profit has shrunk by 65% YoY but it has increased by 5% QoQ
Conformis's gross margin has decreased by 43% YoY but it has increased by 2.2% QoQ
Conformis's revenue has decreased by 38% YoY but it has increased by 3.3% QoQ
Conformis's operating margin has increased by 25% QoQ

Growth

What is Conformis's growth rate over time

Valuation

What is Conformis stock price valuation
P/E
N/A
P/B
0.17
P/S
0.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.2
The EPS rose by 21% since the previous quarter
The stock's price to book (P/B) is 95% less than its 5-year quarterly average of 3.3 and 79% less than its last 4 quarters average of 0.8
The equity has contracted by 46% YoY and by 11% from the previous quarter
The stock's price to sales (P/S) is 88% less than its 5-year quarterly average of 1.2 and 83% less than its last 4 quarters average of 0.8
Conformis's revenue has decreased by 38% YoY but it has increased by 3.3% QoQ

Efficiency

How efficient is Conformis business performance
The return on sales rose by 21% since the previous quarter
The company's return on invested capital rose by 20% QoQ
CFMS's return on assets is up by 10% since the previous quarter
CFMS's return on equity is up by 6% since the previous quarter

Dividends

What is CFMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CFMS.

Financial health

How did Conformis financials performed over time
The total assets is 136% more than the total liabilities
The total assets is down by 35% YoY and by 10% from the previous quarter
Conformis's quick ratio has decreased by 32% YoY but it has increased by 5% QoQ
Conformis's debt is 49% lower than its equity
Conformis's debt to equity has surged by 82% YoY and by 11% QoQ
The equity has contracted by 46% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.